| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1005367340 |
| P356 | DOI | 10.1186/1471-2474-11-192 |
| P932 | PMC publication ID | 2936350 |
| P698 | PubMed publication ID | 20799941 |
| P5875 | ResearchGate publication ID | 46034262 |
| P50 | author | Cezmi Akdis | Q86752470 |
| P2093 | author name string | Cigdem Aydin | |
| Salih Sanlioglu | |||
| Reginald M Gorczynski | |||
| Nilufer Balci | |||
| Huseyin Bagci | |||
| Burcak Yoldas | |||
| Veli Yazisiz | |||
| Atil Bisgin | |||
| Ender Terzioglu | |||
| P2860 | cites work | Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity | Q33497763 |
| Angiogenesis and arthritis | Q33644022 | ||
| Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l | Q33849293 | ||
| Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis | Q34126840 | ||
| T cell homeostasis in patients with rheumatoid arthritis | Q35200330 | ||
| T cell homeostasis in tolerance and immunity | Q36128016 | ||
| Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression | Q36368539 | ||
| CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis | Q36524672 | ||
| The TRAIL to arthritis | Q36524935 | ||
| T-cell-targeted therapies in rheumatoid arthritis | Q36577464 | ||
| What is the place of recently approved T cell-targeted and B cell-targeted therapies in the treatment of rheumatoid arthritis? Lessons from global clinical trials. | Q36870706 | ||
| CD4+CD25high T cell numbers are enriched in the peripheral blood of patients with rheumatoid arthritis. | Q36978507 | ||
| DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells | Q40081513 | ||
| Decoy receptor-2 small interfering RNA (siRNA) strategy employing three different siRNA constructs in combination defeats adenovirus-transferred tumor necrosis factor-related apoptosis-inducing ligand resistance in lung cancer cells | Q40190721 | ||
| Adenovirus-mediated IKKbetaKA expression sensitizes prostate carcinoma cells to TRAIL-induced apoptosis | Q40391803 | ||
| Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model | Q40399578 | ||
| Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium | Q40643863 | ||
| T-cell-dependent pathways in rheumatoid arthritis | Q41515699 | ||
| Major histocompatibility complex-directed susceptibility to rheumatoid arthritis | Q41722145 | ||
| Pathogenesis of rheumatoid arthritis | Q42648866 | ||
| Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy | Q42971266 | ||
| Macrophage-neutrophil interaction: a paradigm for chronic inflammation revisited | Q43742836 | ||
| Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma | Q44259102 | ||
| Differential expression of TRAIL and its receptors in benign and malignant prostate tissues | Q45864366 | ||
| Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis | Q45866146 | ||
| TRAIL death receptor-4 expression positively correlates with the tumor grade in breast cancer patients with invasive ductal carcinoma | Q45868263 | ||
| High levels of endogenous tumor necrosis factor-related apoptosis-inducing ligand expression correlate with increased cell death in human pancreas | Q45877017 | ||
| High TRAIL death receptor 4 and decoy receptor 2 expression correlates with significant cell death in pancreatic ductal adenocarcinoma patients. | Q45881203 | ||
| Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats. | Q45886657 | ||
| FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death | Q46804707 | ||
| Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells. | Q52971040 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid | Q56903335 | ||
| CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
| Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis | Q57350588 | ||
| Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus | Q74169341 | ||
| Functional analysis of TRAIL receptors using monoclonal antibodies | Q74595834 | ||
| Review: angiogenesis: implications for rheumatoid arthritis | Q74648923 | ||
| TRAIL: a molecule with multiple receptors and control mechanisms | Q77485552 | ||
| Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus | Q77918673 | ||
| Apoptosis and autoimmunity | Q78020438 | ||
| Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice | Q78954628 | ||
| The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus | Q81355007 | ||
| Restricted expression of tumor necrosis factor-related apoptosis-inducing ligand receptor 4 in human peripheral blood lymphocytes | Q81789732 | ||
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 192 | |
| P577 | publication date | 2010-08-27 | |
| P1433 | published in | BMC Musculoskeletal Disorders | Q15751716 |
| P1476 | title | TRAIL death receptor-4, decoy receptor-1 and decoy receptor-2 expression on CD8+ T cells correlate with the disease severity in patients with rheumatoid arthritis | |
| P478 | volume | 11 |
| Q52777580 | An apoptosis-independent role of TRAIL in suppressing joint inflammation and inhibiting T-cell activation in inflammatory arthritis. |
| Q64123202 | Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis |
| Q34153021 | Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer |
| Q42138356 | LeEix1 functions as a decoy receptor to attenuate LeEix2 signaling |
| Q64929228 | Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction. |
| Q38093215 | Rheumatoid arthritis in the elderly and its relationship with periodontitis: a review |
| Q39042798 | Serum soluble tumour necrosis factor related apoptosis-inducing ligand level and peripheral eosinophil count in patients with nasal polyposis |
| Q36577451 | Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment |
| Q38070361 | TNF-related apoptosis-inducing ligand (TRAIL) in rheumatoid arthritis: what's new? |
| Q50576783 | TRAIL in CD8+ T cells from patients with severe aplastic anemia. |
| Q39263297 | TRAIL-NP hybrids for cancer therapy: a review. |
| Q64078760 | TRAIL-R1 and TRAIL-R2 Mediate TRAIL-Dependent Apoptosis in Activated Primary Human B Lymphocytes |
Search more.